CULTURE Thai hospital joins hands with China's medical institute to conduct cancer immunotherapy research

CULTURE

Thai hospital joins hands with China's medical institute to conduct cancer immunotherapy research

Xinhua

02:50, December 24, 2019

cancer immunotherapy (ap).jpg

(Photo: AP)

BANGKOK, Dec. 23 (Xinhua) -- Thailand's oldest hospital on Monday announced cooperation with China's Shenzhen Geno-immune Medical Institute (GIMI) to conduct clinical research into cancer immunotherapy.

Dr. Prasit Watanapa, dean of the Faculty of Medicine, Siriraj Hospital, and Dr. Zhang Longji, chairman of GIMI, signed a Memorandum of Understanding (MoU) on Research Cooperation on Monday at Siriraj Hospital.

Using GIMI's cell-based immunotherapy, Siriraj and GIMI will conduct research on gene therapies for leukemia and lymphoma, said Prasit.

"Immunotherapy was an ideal solution to patients with chemotherapy resistance," said Prasit, "The results could help lower treatment costs by over 10 times."

With the cooperation with GIMI, Siriraj Hospital will expand its immunotherapy research to other types of cancers, Prasit said.

Immunotherapy is a cancer treatment that uses a patient's own immune system to fight tumours instead of more commonly known techniques to eliminate malignant cells with radiation or drugs.

Shenzhen Genoimmune Medical Institute is founded by Shenzhen Government in 2015. The key function and goal of this institute are to provide contracted research & technical services for individually cell-based immunotherapy.


Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue